Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies
- 30 April 2004
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (4) , 467-475
- https://doi.org/10.4065/79.4.467
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Antiphospholipid syndromeJournal of the Royal Society of Medicine, 2002
- Antiphospholipid Syndrome and Perioperative Hemostatic Management of Cardiac Valvular SurgeryMayo Clinic Proceedings, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and DeathStroke, 1997
- Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosisKidney International, 1995
- Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies.Annals of the Rheumatic Diseases, 1988
- Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.Annals of the Rheumatic Diseases, 1988
- Cerebrovascular ischemia associated with lupus anticoagulant.Stroke, 1987
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985
- Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 casesAmerican Journal of Hematology, 1985